Picture of Genmab A/S logo

GMAB Genmab A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Brief: Genmab Announces Q1 Nets Sales Of Darzalex

April 15 (Reuters) - Genmab A/S GMAB.CO:

ANNOUNCES NET SALES OF DARZALEX (DARATUMUMAB) FOR FIRST QUARTER OF 2025

NET TRADE SALES OF DARZALEX  SOLD UNDER TRADENAME DARZALEX FASPRO IN U.S.), AS REPORTED BY J&J WERE USD 3,237 MILLION IN Q1 OF 2025

NET TRADE SALES WERE USD 1,829 MILLION IN U.S. AND USD 1,409 MILLION IN REST OF WORLD

Source text: ID:nGNE97RSw0

Further company coverage: GMAB.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Genmab A/S

See all news